Among Short Oral Presentations already accepted
Mitochondria-Specific Genistein Lipidic Nanocarriers
Tamer Elbayoumi, Midwestern University, College, Glendale, USA
An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-AtheroscleroticEffect beyond Plasma Cholesterol-Lowering Activity in apoe-/-Mice
Rolf Berge, Department of Clinical Science, University of Bergen, Bergen, Norway
The Mitosafe Bioenergetic Balance Screening (BBS): An Innovative Method to Profile Modulatorsof the Mitochondrial Metabolic Functions
Emilie Cornille-Robert, ICDD, Predictive Toxicity Department, Meyreuil, France
Implication of Modulation of Mitochondrial Functional Events by Astrocytes in Neuroprotection
David R. Harder, Medical College of Wisconsin, Milwaukee, USA
Characterization of Proteins involved in RNA Trafficking into Human Mitochondria
Ali Gowher,University Of Strasbourg - CNRS, Strasbourg, France
Bornavirus X Protein: A New Tool against Neurodegenerative Disorders?
Marion Szelechowski, INSERM, CHU Purpan, Toulouse, France
Calcium co-Regulates Oxidative Metabolism and ATP-Synthase Dependent Respiration in Pancreatic Beta-Cells
Umberto De Marchi, Nestlé Institute of Health Sciences, Lausanne, Switzerland
Damaged Mitochondrial DNA, a Novel Putative Target for Treatment of Diabetic Complications and Other Diseases of Mitochondrial Dysfunction
Afshan Malik, King’s College London, London, United Kingdom
Mitochondrial Targeting Cell Penetrating Peptides: A New Mitochondrial Peptide Based Gene Delivery System
Trevor MacMillan, Agriculture and Agri-Food Canada, Lethbridge Research Centre, Lethbridge, Canada
Low Abundance of the Matrix Arm of Complex I in the Mitochondria Predicts Longevity
Thomas Von Zglinicki, Institute for Ageing and Health, Newcastle University, Newcastle, United Kingdom
Changed Mitochondrial Properties after Expression of Ciona Intestinalis Alternative Oxidase (Aox)in Mouse Heart
Frank N. Gellerich, Otto-Von-Guericke University, Magdeburg, Germany
The Measurement of Nitrotyrosine in Blood as an Early Predictive Parameter of Nitrosative Stress
and Functional Mitochondriopathy
Clauss Muss, St. Elisabeth Universität für Forschung und Soziales, Bratislava, Slovakia
Ataxia and Mitochondrial Disease
Melanie Buchmann, Newcastle University, Newcastle, United Kingdom
Targeting SK2 mitochondrial channels: A Promising Target for Neuroprotective Strategies
Pr Carsten Culmsee is Full Professor for Clinical Pharmacy at Philipps-Universitaet Marburg, Germany. He is specialized on research of mechanisms of neuronal cell death and brain damage.
A new talk of Targeting Mitochondria 2013: Carbon Nanotubes for Mitochondrial Targeting
During Targeting Mitochondria 2013, Dr Alessia Battigelli from CNRS Strasbourg, France will talk about Carbon Nanotubes for Mitochondrial Targeting.
The first 3D disease map of mitochondrial protein will be presented by Dr R. Lloyd during Targeting Mitochondria 2013
Dr Rhiannon Lloyd from the Institute of Biomedical and Biomolecular Sciences, University of Portsmouth, UK, will present a talk on her recent work using 3D structural analysis of mitochondrial mutations to predict their pathological outcome. The study is a result of collaboration between Dr Lloyd, a mitochondrial biologist, and Dr John McGeehan, a structural biologist.
Redox Signaling Pathways Modulation and Mitochondria: Hot Topic to be discussed during Targeting Mitochondria 2013
During ISANH Congress on Antioxidants organized in Paris on July 3-4, 2013 (www.isanh.fr), which celebrate the 15th Anniversary of the creation of ISANH, one of the main discussion showed that antioxidants play their role by modulating redox signaling pathways and not a counter "balance" to oxidant formation. They act to modulate cells signaling domains in which redox signaling occurs.
Mitochondria are a localized signlaing domain and ROS (Superoxidase and Hydrogen Peroxidase) generated by respiratory chain are signaling molecules.
Mitochondrial Uncoupling Proteins and its Role in Cancer will be highlighted by Pr Keshav Singh
Pr Keshav Singh, Founder of Mitochondria Research and Medicine Society and Professor of Genetics, Pathology and Environmental Health at University of Alabama at Birmingham will give a talk during the 4th edition of Targeting Mitochondria 2013.
Nanofluidic Platform for Single Mitochondria Analysis using Fluorescence Microscopy: Strategic Topic will be highlihghted by Pr Douglas Wallace
The Scientific Committee of Targeting Mitochondria 2013 asked Pr Wallace to present the recent studies relaized in collaboration with Pr Peter J. Burke from the University of Integrated Nanosystem Research Facility, Electrical Engineering and Computer Science, University of California, Irvine, California. This study was published in Analytical Chemistry last May.
Mitochondria-Targeted Nanoparticles for Atherosclerosis and Cancer: A Update of Research presented by Dr Shanta Dhar during Targeting Mitochondria 2013
Dr Shanta Dhar, from University of Georgia, USA was awarded in 2012 by the Scientific Committee of Targeting Mitochondria.
She will update her researches about Mitochondria-Targeted Nanoparticules for Atherosclerosis and Cancer during the 4th Edition of Targeting Mitochondria World Congress 2013.
The Scientific Committee of Targeting Mitochondria 2013 announced the list of Speakers next Targeting Mitochondria World Congress
On behalf of Scientific Committee of Targeting Mitochondria 2013, Pr Marvin Edeas & Pr Volkmar Weissig, we are honoured to welcoming high quality speakers for the fourth edition of Targeting Mitochondria 2013, which will be held in Berlin on October 17-18, 2013.
Mitochondrial dysfunction modifies stem cell function: A hot Topic of Targeting Mitochondria 2013
Integrity of mitochondrial genome is essential for proper function of stem cells. It is the hot topic presented by Riikka Hamalainen, from University of Helsinki, Finland during the next World Congress on Targeting Mitochondria 2013.Dr Laurent Chatre, from Pasteur Institute, Paris will present a Novel Imaging Tool to Diagnose in situ Mitochondrial DNA Processing Dysfunction during next Targeting Mitochondria World Congress
To date, mitochondrial transcripts and mitochondrial DNA (mtDNA) replication dynamics at the single-cell level were poorly informative of mitochondrial dysfunction.
Pr Douglas Wallace: Key speaker of Targeting Mitochondria 2013
The Scientific Committee of Targeting Mitochondria 2013 is honoured to announce that Pr Douglas Wallace, from Center for Mitochondrial and Epigenomic Medicine, Philadelphia, USA will introduce the fourth edition of the world congress on Targeting Mitochondria 2013, which will be held in Berlin in October 17-18, 2013.
Dr Gerard D'Souza was awarded by Targeting Mitochondria 2012 Scientific Committee
Dr Gerard D'Souza from Massachusetts College of Pharmacy and Health Sciences, USA, was awarded during Targeting Mitochondria 2012 for his scientific contribution for his work about Functional Expression of Green Fluorescent Protein in Mitochondria of Rat Cells Following Liposome-Mediated Delivery of a Linear DNA Construct.
Scientific Committee of Targeting Mitochondria awarded Dr Shanta Dhar for her work
During Targeting Mitochondria 2012, the Scientific Committee awarded Dr Shanta Dhar for her Scientific Contribution.
More Articles...
- Pr Shanta Dhar will present recent researches about Delivering drugs via nanoparticles to target mitochondria: Positive results shown for cancer, Alzheimer’s and obesity drugs during Targeting Mitochondria 2012
- Targeting Mitochondria Networking 2012 is organized around Cocktail and Snacks with international companies and academics
- Cationic derivative of plastoquinone (visomitin), the first mitochondria-targeted medicine available in drugstores
- Two hot topics for Targeting Mitochondria 2012: Mito-Devices & Mito-Engineering
